静脈内点滴療法と静脈アクセスの世界市場 2023-2027

静脈内点滴療法と静脈アクセス市場2023-2027

静脈内点滴療法と静脈アクセス市場は2022-2027年に67億8,910万米ドル、予測期間中のCAGRは5.01％で成長すると予測されます。当レポートでは、静脈内点滴療法と静脈アクセス市場の全体的な分析、市場規模・予測、動向、市場促進要因・促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、慢性疾患の有病率の増加、老人人口の増加、非経口栄養に対する需要の増加によって牽引されています。

本調査では、今後数年間における静脈内点滴療法と静脈アクセス市場の成長を促進する主な要因の1つとして、点滴ソリューションの技術的進歩を挙げています。また、治療に使用される静脈注射薬の承認数の増加、ヘルスケア支出とヘルスケア保険の増加は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し 2022-2027

第4章 市場規模実績

• 静脈内点滴療法と静脈アクセスの世界市場 2017-2021
• エンドユーザーセグメント分析 2017-2021
• 用途別セグメント分析 2017-2021
• 地域別セグメント分析 2017-2021
• 国別セグメント分析 2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：エンドユーザー別

• 市場セグメント
• 比較：エンドユーザー別
• 病院：市場規模と予測 2022-2027
• クリニック：市場規模と予測 2022-2027
• 外来手術センター：市場規模と予測 2022-2027
• 市場機会：エンドユーザー別

第7章 市場セグメンテーション：用途別

• 市場セグメント
• 比較：用途別
• 投薬管理：市場規模と予測 2022-2027
• 血液ベースの製品：市場規模と予測 2022-2027
• 栄養剤および緩衝液：市場規模と予測 2022-2027
• ボリュームエキスパンダー：市場規模と予測 2022-2027
• 市場機会：用途別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2022-2027
• 欧州：市場規模と予測 2022-2027
• アジア：市場規模と予測 2022-2027
• 世界のその他の地域：市場規模と予測 2022-2027
• 米国：市場規模と予測 2022-2027
• ドイツ：市場規模と予測 2022-2027
• 日本：市場規模と予測 2022-2027
• フランス：市場規模と予測 2022-2027
• カナダ：市場規模と予測 2022-2027
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AngioDynamics Inc.
• B.Braun SE
• Baxter International Inc.
• Becton Dickinson and Co.
• Cardinal Health Inc.
• Fresenius SE and Co. KGaA
• ICU Medical Inc.
• IRadimed Corp.
• Medtronic Plc
• Poly Medicure Ltd.
• Smith and Nephew plc
• Tekni Plex Inc.
• Teleflex Inc.
• Terumo Corp.
• Vygon SAS

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits6: Executive Summary - Chart on Market Segmentation by Application
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on global intravenous iv therapy and vein access market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on End-user - Market share 2022-2027 (%)
• Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by End-user
• Exhibits33: Data Table on Comparison by End-user
• Exhibits34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Clinics - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
• Exhibits43: Data Table on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
• Exhibits44: Chart on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
• Exhibits46: Market opportunity by End-user ($ million)
• Exhibits47: Data Table on Market opportunity by End-user ($ million)
• Exhibits48: Chart on Application - Market share 2022-2027 (%)
• Exhibits49: Data Table on Application - Market share 2022-2027 (%)
• Exhibits50: Chart on Comparison by Application
• Exhibits51: Data Table on Comparison by Application
• Exhibits52: Chart on Medication administration - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Data Table on Medication administration - Market size and forecast 2022-2027 ($ million)
• Exhibits54: Chart on Medication administration - Year-over-year growth 2022-2027 (%)
• Exhibits55: Data Table on Medication administration - Year-over-year growth 2022-2027 (%)
• Exhibits56: Chart on Blood-based products - Market size and forecast 2022-2027 ($ million)
• Exhibits57: Data Table on Blood-based products - Market size and forecast 2022-2027 ($ million)
• Exhibits58: Chart on Blood-based products - Year-over-year growth 2022-2027 (%)
• Exhibits59: Data Table on Blood-based products - Year-over-year growth 2022-2027 (%)
• Exhibits60: Chart on Nutrition and buffer solution - Market size and forecast 2022-2027 ($ million)
• Exhibits61: Data Table on Nutrition and buffer solution - Market size and forecast 2022-2027 ($ million)
• Exhibits62: Chart on Nutrition and buffer solution - Year-over-year growth 2022-2027 (%)
• Exhibits63: Data Table on Nutrition and buffer solution - Year-over-year growth 2022-2027 (%)
• Exhibits64: Chart on Volume expander - Market size and forecast 2022-2027 ($ million)
• Exhibits65: Data Table on Volume expander - Market size and forecast 2022-2027 ($ million)
• Exhibits66: Chart on Volume expander - Year-over-year growth 2022-2027 (%)
• Exhibits67: Data Table on Volume expander - Year-over-year growth 2022-2027 (%)
• Exhibits68: Market opportunity by Application ($ million)
• Exhibits69: Data Table on Market opportunity by Application ($ million)
• Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits73: Chart on Geographic comparison
• Exhibits74: Data Table on Geographic comparison
• Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits85: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits101: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits103: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibits104: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibits105: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibits106: Data Table on France - Year-over-year growth 2022-2027 (%)
• Exhibits107: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits108: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits109: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits111: Market opportunity By Geographical Landscape ($ million)
• Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits113: Impact of drivers and challenges in 2022 and 2027
• Exhibits114: Overview on Criticality of inputs and Factors of differentiation
• Exhibits115: Overview on factors of disruption
• Exhibits116: Impact of key risks on business
• Exhibits117: Vendors covered
• Exhibits118: Matrix on vendor position and classification
• Exhibits119: AngioDynamics Inc. - Overview
• Exhibits120: AngioDynamics Inc. - Business segments
• Exhibits121: AngioDynamics Inc. - Key news
• Exhibits122: AngioDynamics Inc. - Key offerings
• Exhibits123: AngioDynamics Inc. - Segment focus
• Exhibits124: B.Braun SE - Overview
• Exhibits125: B.Braun SE - Business segments
• Exhibits126: B.Braun SE - Key news
• Exhibits127: B.Braun SE - Key offerings
• Exhibits128: B.Braun SE - Segment focus
• Exhibits129: Baxter International Inc. - Overview
• Exhibits130: Baxter International Inc. - Business segments
• Exhibits131: Baxter International Inc. - Key news
• Exhibits132: Baxter International Inc. - Key offerings
• Exhibits133: Baxter International Inc. - Segment focus
• Exhibits134: Becton Dickinson and Co. - Overview
• Exhibits135: Becton Dickinson and Co. - Business segments
• Exhibits136: Becton Dickinson and Co. - Key news
• Exhibits137: Becton Dickinson and Co. - Key offerings
• Exhibits138: Becton Dickinson and Co. - Segment focus
• Exhibits139: Cardinal Health Inc. - Overview
• Exhibits140: Cardinal Health Inc. - Business segments
• Exhibits141: Cardinal Health Inc. - Key news
• Exhibits142: Cardinal Health Inc. - Key offerings
• Exhibits143: Cardinal Health Inc. - Segment focus
• Exhibits144: Fresenius SE and Co. KGaA - Overview
• Exhibits145: Fresenius SE and Co. KGaA - Business segments
• Exhibits146: Fresenius SE and Co. KGaA - Key news
• Exhibits147: Fresenius SE and Co. KGaA - Key offerings
• Exhibits148: Fresenius SE and Co. KGaA - Segment focus
• Exhibits149: ICU Medical Inc. - Overview
• Exhibits150: ICU Medical Inc. - Product / Service
• Exhibits151: ICU Medical Inc. - Key offerings
• Exhibits152: IRadimed Corp. - Overview
• Exhibits153: IRadimed Corp. - Product / Service
• Exhibits154: IRadimed Corp. - Key offerings
• Exhibits155: Medtronic Plc - Overview
• Exhibits156: Medtronic Plc - Business segments
• Exhibits157: Medtronic Plc - Key news
• Exhibits158: Medtronic Plc - Key offerings
• Exhibits159: Medtronic Plc - Segment focus
• Exhibits160: Poly Medicure Ltd. - Overview
• Exhibits161: Poly Medicure Ltd. - Product / Service
• Exhibits162: Poly Medicure Ltd. - Key offerings
• Exhibits163: Smith and Nephew plc - Overview
• Exhibits164: Smith and Nephew plc - Business segments
• Exhibits165: Smith and Nephew plc - Key news
• Exhibits166: Smith and Nephew plc - Key offerings
• Exhibits167: Smith and Nephew plc - Segment focus
• Exhibits168: Tekni Plex Inc. - Overview
• Exhibits169: Tekni Plex Inc. - Product / Service
• Exhibits170: Tekni Plex Inc. - Key offerings
• Exhibits171: Teleflex Inc. - Overview
• Exhibits172: Teleflex Inc. - Business segments
• Exhibits173: Teleflex Inc. - Key news
• Exhibits174: Teleflex Inc. - Key offerings
• Exhibits175: Teleflex Inc. - Segment focus
• Exhibits176: Terumo Corp. - Overview
• Exhibits177: Terumo Corp. - Business segments
• Exhibits178: Terumo Corp. - Key news
• Exhibits179: Terumo Corp. - Key offerings
• Exhibits180: Terumo Corp. - Segment focus
• Exhibits181: Vygon SAS - Overview
• Exhibits182: Vygon SAS - Product / Service
• Exhibits183: Vygon SAS - Key offerings
• Exhibits184: Inclusions checklist
• Exhibits185: Exclusions checklist
• Exhibits186: Currency conversion rates for US$
• Exhibits187: Research methodology
• Exhibits188: Validation techniques employed for market sizing
• Exhibits189: Information sources
• Exhibits190: List of abbreviations

Intravenous IV therapy And Vein Access Market 2023-2027

The intravenous IV therapy and vein access market is forecasted to grow by USD 6,789.1 mn during 2022-2027, accelerating at a CAGR of 5.01% during the forecast period. The report on the intravenous IV therapy and vein access market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, increase in geriatric population, and increasing demand for parenteral nutrition.

Technavio's intravenous IV therapy and vein access market is segmented as below:

By End-user

• Hospitals
• Clinics
• Ambulatory surgical centers

By Application

• Medication administration
• Blood-based products
• Nutrition and buffer solution
• Volume expander

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the technological advancements in IV solutions as one of the prime reasons driving the intravenous IV therapy and vein access market growth during the next few years. Also, increase in number of approved iv drugs used for therapy and an increase in healthcare expenditure and healthcare insurance will lead to sizable demand in the market.

The report on the intravenous IV therapy and vein access market covers the following areas:

• Intravenous IV therapy and vein access market sizing
• Intravenous IV therapy and vein access market forecast
• Intravenous IV therapy and vein access market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading intravenous IV therapy and vein access market vendors that include AngioDynamics Inc., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Cardinal Health Inc., Fresenius SE and Co. KGaA, ICU Medical Inc., IRadimed Corp., Medtronic Plc, Poly Medicure Ltd., Smith and Nephew plc, Tekni Plex Inc., Teleflex Inc., Terumo Corp., and Vygon SAS. Also, the intravenous IV therapy and vein access market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global intravenous IV therapy and vein access market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on global intravenous iv therapy and vein access market 2017 - 2021 ($ million)
• 4.2 End-user Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
• 4.3 Application Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

• 6.1 Market segments
• Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
• 6.2 Comparison by End-user
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user
• 6.3 Hospitals - Market size and forecast 2022-2027
• Exhibit 34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
• 6.4 Clinics - Market size and forecast 2022-2027
• Exhibit 38: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Clinics - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
• 6.5 Ambulatory surgical centers - Market size and forecast 2022-2027
• Exhibit 42: Chart on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
• 6.6 Market opportunity by End-user
• Exhibit 46: Market opportunity by End-user ($ million)
• Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Application

• 7.1 Market segments
• Exhibit 48: Chart on Application - Market share 2022-2027 (%)
• Exhibit 49: Data Table on Application - Market share 2022-2027 (%)
• 7.2 Comparison by Application
• Exhibit 50: Chart on Comparison by Application
• Exhibit 51: Data Table on Comparison by Application
• 7.3 Medication administration - Market size and forecast 2022-2027
• Exhibit 52: Chart on Medication administration - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Medication administration - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Medication administration - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Medication administration - Year-over-year growth 2022-2027 (%)
• 7.4 Blood-based products - Market size and forecast 2022-2027
• Exhibit 56: Chart on Blood-based products - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Blood-based products - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Blood-based products - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Blood-based products - Year-over-year growth 2022-2027 (%)
• 7.5 Nutrition and buffer solution - Market size and forecast 2022-2027
• Exhibit 60: Chart on Nutrition and buffer solution - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Nutrition and buffer solution - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Nutrition and buffer solution - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Nutrition and buffer solution - Year-over-year growth 2022-2027 (%)
• 7.6 Volume expander - Market size and forecast 2022-2027
• Exhibit 64: Chart on Volume expander - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Data Table on Volume expander - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Chart on Volume expander - Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on Volume expander - Year-over-year growth 2022-2027 (%)
• 7.7 Market opportunity by Application
• Exhibit 68: Market opportunity by Application ($ million)
• Exhibit 69: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 73: Chart on Geographic comparison
• Exhibit 74: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.9 Japan - Market size and forecast 2022-2027
• Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• 9.10 France - Market size and forecast 2022-2027
• Exhibit 103: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on France - Year-over-year growth 2022-2027 (%)
• 9.11 Canada - Market size and forecast 2022-2027
• Exhibit 107: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 108: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 109: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 111: Market opportunity By Geographical Landscape ($ million)
• Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 113: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 115: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 116: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 117: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 118: Matrix on vendor position and classification
• 12.3 AngioDynamics Inc.
• Exhibit 119: AngioDynamics Inc. - Overview
• Exhibit 120: AngioDynamics Inc. - Business segments
• Exhibit 121: AngioDynamics Inc. - Key news
• Exhibit 122: AngioDynamics Inc. - Key offerings
• Exhibit 123: AngioDynamics Inc. - Segment focus
• 12.4 B.Braun SE
• Exhibit 124: B.Braun SE - Overview
• Exhibit 125: B.Braun SE - Business segments
• Exhibit 126: B.Braun SE - Key news
• Exhibit 127: B.Braun SE - Key offerings
• Exhibit 128: B.Braun SE - Segment focus
• 12.5 Baxter International Inc.
• Exhibit 129: Baxter International Inc. - Overview
• Exhibit 130: Baxter International Inc. - Business segments
• Exhibit 131: Baxter International Inc. - Key news
• Exhibit 132: Baxter International Inc. - Key offerings
• Exhibit 133: Baxter International Inc. - Segment focus
• 12.6 Becton Dickinson and Co.
• Exhibit 134: Becton Dickinson and Co. - Overview
• Exhibit 135: Becton Dickinson and Co. - Business segments
• Exhibit 136: Becton Dickinson and Co. - Key news
• Exhibit 137: Becton Dickinson and Co. - Key offerings
• Exhibit 138: Becton Dickinson and Co. - Segment focus
• 12.7 Cardinal Health Inc.
• Exhibit 139: Cardinal Health Inc. - Overview
• Exhibit 140: Cardinal Health Inc. - Business segments
• Exhibit 141: Cardinal Health Inc. - Key news
• Exhibit 142: Cardinal Health Inc. - Key offerings
• Exhibit 143: Cardinal Health Inc. - Segment focus
• 12.8 Fresenius SE and Co. KGaA
• Exhibit 144: Fresenius SE and Co. KGaA - Overview
• Exhibit 145: Fresenius SE and Co. KGaA - Business segments
• Exhibit 146: Fresenius SE and Co. KGaA - Key news
• Exhibit 147: Fresenius SE and Co. KGaA - Key offerings
• Exhibit 148: Fresenius SE and Co. KGaA - Segment focus
• 12.9 ICU Medical Inc.
• Exhibit 149: ICU Medical Inc. - Overview
• Exhibit 150: ICU Medical Inc. - Product / Service
• Exhibit 151: ICU Medical Inc. - Key offerings
• 12.10 IRadimed Corp.
• Exhibit 152: IRadimed Corp. - Overview
• Exhibit 153: IRadimed Corp. - Product / Service
• Exhibit 154: IRadimed Corp. - Key offerings
• 12.11 Medtronic Plc
• Exhibit 155: Medtronic Plc - Overview
• Exhibit 156: Medtronic Plc - Business segments
• Exhibit 157: Medtronic Plc - Key news
• Exhibit 158: Medtronic Plc - Key offerings
• Exhibit 159: Medtronic Plc - Segment focus
• 12.12 Poly Medicure Ltd.
• Exhibit 160: Poly Medicure Ltd. - Overview
• Exhibit 161: Poly Medicure Ltd. - Product / Service
• Exhibit 162: Poly Medicure Ltd. - Key offerings
• 12.13 Smith and Nephew plc
• Exhibit 163: Smith and Nephew plc - Overview
• Exhibit 164: Smith and Nephew plc - Business segments
• Exhibit 165: Smith and Nephew plc - Key news
• Exhibit 166: Smith and Nephew plc - Key offerings
• Exhibit 167: Smith and Nephew plc - Segment focus
• 12.14 Tekni Plex Inc.
• Exhibit 168: Tekni Plex Inc. - Overview
• Exhibit 169: Tekni Plex Inc. - Product / Service
• Exhibit 170: Tekni Plex Inc. - Key offerings
• 12.15 Teleflex Inc.
• Exhibit 171: Teleflex Inc. - Overview
• Exhibit 172: Teleflex Inc. - Business segments
• Exhibit 173: Teleflex Inc. - Key news
• Exhibit 174: Teleflex Inc. - Key offerings
• Exhibit 175: Teleflex Inc. - Segment focus
• 12.16 Terumo Corp.
• Exhibit 176: Terumo Corp. - Overview
• Exhibit 177: Terumo Corp. - Business segments
• Exhibit 178: Terumo Corp. - Key news
• Exhibit 179: Terumo Corp. - Key offerings
• Exhibit 180: Terumo Corp. - Segment focus
• 12.17 Vygon SAS
• Exhibit 181: Vygon SAS - Overview
• Exhibit 182: Vygon SAS - Product / Service
• Exhibit 183: Vygon SAS - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 184: Inclusions checklist
• Exhibit 185: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 186: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 187: Research methodology
• Exhibit 188: Validation techniques employed for market sizing
• Exhibit 189: Information sources
• 13.5 List of abbreviations
• Exhibit 190: List of abbreviations